Ainos (AIMD) Competitors $0.55 +0.01 (+1.83%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock AIMD vs. SRZN, AKTX, COEP, OSTX, ESLA, INKT, CVKD, MRNS, KZR, and LVTXShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Surrozen (SRZN), Akari Therapeutics (AKTX), Coeptis Therapeutics (COEP), OS Therapies (OSTX), Estrella Immunopharma (ESLA), MiNK Therapeutics (INKT), Cadrenal Therapeutics (CVKD), Marinus Pharmaceuticals (MRNS), Kezar Life Sciences (KZR), and LAVA Therapeutics (LVTX). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Surrozen Akari Therapeutics Coeptis Therapeutics OS Therapies Estrella Immunopharma MiNK Therapeutics Cadrenal Therapeutics Marinus Pharmaceuticals Kezar Life Sciences LAVA Therapeutics Surrozen (NASDAQ:SRZN) and Ainos (NASDAQ:AIMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, community ranking, dividends and earnings. Do insiders & institutionals have more ownership in SRZN or AIMD? 66.6% of Surrozen shares are owned by institutional investors. 43.5% of Surrozen shares are owned by company insiders. Comparatively, 10.4% of Ainos shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has stronger valuation and earnings, SRZN or AIMD? Ainos has lower revenue, but higher earnings than Surrozen. Surrozen is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$10.66M3.00-$43.04M-$21.77-0.45Ainos$20.73K409.48-$13.77M-$1.65-0.33 Does the MarketBeat Community believe in SRZN or AIMD? Surrozen received 6 more outperform votes than Ainos when rated by MarketBeat users. CompanyUnderperformOutperformSurrozenOutperform Votes628.57% Underperform Votes1571.43% AinosN/AN/A Do analysts rate SRZN or AIMD? Surrozen currently has a consensus price target of $38.50, suggesting a potential upside of 294.87%. Given Surrozen's stronger consensus rating and higher possible upside, equities analysts clearly believe Surrozen is more favorable than Ainos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SRZN or AIMD more profitable? Ainos' return on equity of -75.16% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -120.51% -54.68% Ainos N/A -75.16%-50.22% Which has more risk and volatility, SRZN or AIMD? Surrozen has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Ainos has a beta of 1.83, meaning that its stock price is 83% more volatile than the S&P 500. Does the media refer more to SRZN or AIMD? In the previous week, Surrozen and Surrozen both had 1 articles in the media. Surrozen's average media sentiment score of 1.00 beat Ainos' score of 0.50 indicating that Surrozen is being referred to more favorably in the media. Company Overall Sentiment Surrozen Positive Ainos Positive SummarySurrozen beats Ainos on 8 of the 15 factors compared between the two stocks. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMD vs. The Competition Export to ExcelMetricAinosPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.49M$6.46B$5.31B$7.35BDividend YieldN/A3.21%5.45%4.34%P/E Ratio-0.336.9521.9417.82Price / Sales409.48231.01380.6697.73Price / CashN/A65.6738.2534.64Price / Book0.115.936.453.98Net Income-$13.77M$143.22M$3.22B$247.81M7 Day Performance-14.06%4.28%5.85%3.19%1 Month Performance5.75%-13.11%-9.62%-7.70%1 Year Performance-46.60%-8.51%11.79%1.49% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDAinos0.9275 of 5 stars$0.55+1.8%N/A-46.6%$8.49M$20,729.00-0.3340Short Interest ↓Gap UpSRZNSurrozen3.5947 of 5 stars$9.78+3.0%$38.50+293.9%+3.7%$32.07M$10.66M-0.4580Short Interest ↓Positive NewsGap UpHigh Trading VolumeAKTXAkari TherapeuticsN/A$1.20+7.7%N/A+3.2%$31.88MN/A0.009Analyst ForecastNews CoverageCOEPCoeptis Therapeutics0.4396 of 5 stars$9.37-0.4%N/A+51.1%$31.51MN/A-1.612Short Interest ↑News CoverageOSTXOS Therapies1.7783 of 5 stars$1.44+9.9%$18.00+1,150.0%N/A$31.20MN/A0.00N/AESLAEstrella Immunopharma2.9123 of 5 stars$0.85-2.7%$16.00+1,780.1%-25.8%$30.78MN/A-3.27N/AShort Interest ↓Positive NewsGap UpINKTMiNK Therapeutics3.087 of 5 stars$7.75+2.5%$37.50+383.9%-12.9%$30.74MN/A-1.9930Short Interest ↓Positive NewsGap DownCVKDCadrenal Therapeutics1.9742 of 5 stars$16.32+5.6%$32.00+96.1%N/A$30.68MN/A-2.444News CoveragePositive NewsMRNSMarinus Pharmaceuticals2.1249 of 5 stars$0.55-0.2%$4.79+771.6%-60.2%$30.32M$30.99M-0.22110Analyst ForecastNews CoverageKZRKezar Life Sciences3.731 of 5 stars$4.11-4.9%$39.50+861.1%-47.3%$30.03M$7M-0.3160LVTXLAVA Therapeutics2.3783 of 5 stars$1.14-1.7%$3.17+177.8%-51.7%$29.99M$11.98M-1.1160Short Interest ↓Positive News Related Companies and Tools Related Companies SRZN Competitors AKTX Competitors COEP Competitors OSTX Competitors ESLA Competitors INKT Competitors CVKD Competitors MRNS Competitors KZR Competitors LVTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIMD) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIMD Stock Free AIMD Stock Alerts